Opening book details…
Can I read Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology on EtoBox?
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology by Mark L. Kayton; Aaron R. Weiss; Wei Xue; Odion Binitie; Andrea Hayes Dixon; R. Lor Randall; Joel I. Sorger; Douglas S. Hawkins; Sheri L. Spunt; Dian Wang; Lynn Million; Stephanie Terezakis; Edwin Choy; Scott H. Okuno; Rajkumar Venkatramani; Yen‐Lin Chen; Thomas J. Scharschmidt is a Medicine article available to read on EtoBox.
What is Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology about?
Background and Objectives: The impact upon wound healing of targeted molecular therapies, when incorporated into neoadjuvant therapy of soft tissue sarcoma, is largely unknown. Here, we describe wound complications following addition of
Who reads Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Mark L. Kayton; Aaron R. Weiss; Wei Xue; Odion Binitie; Andrea Hayes Dixon; R. Lor Randall; Joel I. Sorger; Douglas S. Hawkins; Sheri L. Spunt; Dian Wang; Lynn Million; Stephanie Terezakis; Edwin Choy; Scott H. Okuno; Rajkumar Venkatramani; Yen‐Lin Chen; Thomas J. Scharschmidt
- Publisher
- Wiley
- Published
- 2023
- Language
- EN
- Field
- Medicine (Health Sciences)